Introduction
The four chambers of a healthy heart are characterized by specific genetic, anatomic, metabolic, physiologic, and electric features. For example, right (RV) and left ventricles (LVs) have different mass, volume, morphology and pressures. 1, 2 Morphological differences also exist between the right and left atrium. 3 Additionally, there are chamber-specific differences in electrophysiological properties 4, 5 including different action potential parameters due to specific expression patterns and function of ion channels. 6, 7 Accordingly, regional heterogeneity between left and right heart chambers also exists for the expression of many genes, 6, [8] [9] [10] [11] [12] [13] microRNAs, 14 as well as frequently used housekeeping genes. 15 19-22 which differ between left and right heart chambers. [23] [24] [25] Although AF is considered to predominantly occur in the left atrium, recent data by Karapinar et al. 26 showed profound changes in the electrical properties in the right atrium of paroxysmal atrial fibrillation (pAF) patients pointing to specific remodelling in the right atrium of these patients. b-adrenoceptor (b-AR) blockers are a well-established therapy for HF, but the b-AR response may differ between left and right ventricles. 5 Although there is clear evidence that altered gene transcription contributes to the pathological cardiac remodelling leading to AF or HF, the precise mechanisms of altered gene transcription are not completely understood. In this context, gene expression profiling of the human heart has become an essential step to study in-depth the molecular regulatory networks that underlie chamber-specific differences between healthy and diseased hearts. Quantitative real-time polymerase chain reaction (RT-qPCR) is the most sensitive and accurate technique to simultaneously amplify and quantify gene expression by measuring the increment of fluorescence in each PCR cycle. However, PCR readouts need an accurate normalization with internal reference genes whose expression has to be stable 27 and independent of the experimental groups or remodelling processes. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 18S ribosomal RNA (18S), b-actin (ACTB) or b2-microglobulin (B2M) have been used extensively as reference genes in RT-qPCR for heart samples. [28] [29] [30] [31] Yet, a number of studies have demonstrated that the expression of some of these classically used housekeeping genes vary significantly according to the species, experimental model, disease condition, tissue type, etc. 30, [32] [33] [34] [35] In human heart, a recent study used human HF samples to select stable housekeeping genes for normalizing gene expression data between HF left and right ventricles, 36 but no optimal set of reference genes has been identified so far for normalizing gene expression data across right and left atria or for comparing the different cardiac cavities in healthy and diseased states. The aim of this study was to assess the expression of 16 classical genes used as housekeeping genes (ACTB, B2M, GAPDH, b-D-glucuronidase (GUSB), hydroxymethylbilane synthase (HMBS), hypoxanthine phosphoribosyltransferase 1 (HPRT1), importin 8 (IPO8), phosphoglycerate kinase 1 (PGK1), RNA polymerase II subunit A (POLR2A), peptidylprolyl isomerase A (PPIA), ribosomal protein lateral stalk subunit P0 (RPLP0), TATA box binding protein (TBP), transferrin receptor (TFRC), ubiquitin C (UBC), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) and 18S ribosomal RNA (18S)) and to select a set of reference genes that can be reliably used for normalization of RT-qPCR experiments in atrial and ventricular tissues from left and right cavities of healthy subjects or patients with AF or HF. A combined analysis of the results using GeNorm 35 and NormFinder 37 algorithms, the BestKeeper 38 software tool and the comparative Delta-Ct method 39 was performed to strengthen and validate the selection of the topranking reference genes in order to propose an optimal set of reference genes across the different heart cavities and cardiac diseases.
Methods

Selection of candidate reference genes
For this study, we used the TaqMan Human Endogenous Control Arrays (Applied Biosystems, Life Technologies, France) which contain commonly used housekeeping genes that exhibit minimal differential expression across many different tissues : ACTB, B2M, GAPDH, GUSB, HMBS,  HPRT1, IPO8, PGK1, POLR2A, PPIA, RPLP0, TBP, TFRC, Table 1 .
The study was conducted in accordance with the Declaration of Helsinki principles, and approved by the Ethical Committees of our institutions. All protocols for obtaining human cardiac tissue were approved by the Ethical Committees and informed consent was obtained before cardiac surgery.
Human tissue samples used for validation of the preselected reference genes
A selection of the above described human heart samples was used to measure expression of two target genes, protein phosphatase 2 catalytic subunit alpha isoform (PPP2CA) in atrial samples and adenylate cyclase type V (ADCY5) in ventricular samples, and validate the proposed set of reference genes. Table 1 summarizes the clinical characteristics of the subset of patients used in this study. Thus, a total of 15 atrial samples from patients subjected to atrial cannulation during surgery and 7 ventricular samples from explanted human hearts were used for this part of the study.
RNA isolation and cDNA synthesis
Frozen tissue samples were weighed and placed in pre-cooled tubes containing TRIzol reagent (Invitrogen, Life Technologies, France) and rapidly subjected to automated grinding in a Bertin Precellys 24 (Bertin Technologies, France). Total RNA extraction was carried out using standard procedure according to the manufacturer's instructions. RNA concentration and purity were evaluated by optical density (OD) (Biophotometer, Eppendorf, BioServ, France) and the integrity of the RNA samples were analyzed on a Bioanalyzer 2100 with the RNA6000 Nano Labchip Kit (Agilent Technologies, Santa Clara, CA, USA). The RNA integrity number (RIN) was calculated by the instrument software. First strand cDNA synthesis was performed from 2 lg of total RNA with random primers and MultiScribe Reverse Transcriptase according to the provided protocol (Applied Biosystems, Life Technologies, France). To minimize intergroup variations, samples of each experimental group were processed simultaneously.
Real-time qPCR and quantification
Real-time PCR assays were performed using TaqMan 384-well microfluidic card technology from Applied Biosystems (TaqMan Array Card or TAC, Life Technologies, France) and the TaqMan Human Endogenous Control Panel. These TAC were designed to study the expression stability of 16 potential reference genes ( Table 2) . As mentioned earlier, the 16 reference genes were chosen by their common use as endogenous control genes. Each PCR reaction was performed on 4 ng of cDNA in a volume of 1 ml. The thermal cycling conditions for PCR amplification on TAC were 10 min at 94. Ct levels are inversely proportional to the amount of target nucleic acid in the sample. Ct is specific to the expression of one gene whereas Delta Ct shows the difference of expression between two genes. This DCt approach can be used to study the stability of candidate housekeeping genes by comparing the relative expression of 'pairs of genes' within each sample. 39 GeNorm algorithm ranks the candidate reference genes by an expression stability measurement called M-value which is the average pairwise variation of a particular gene with all the other reference genes. 35 The most stable genes are the ones with the lowest M-value.
NormFinder algorithm also ranks the set of candidate normalization genes according to their expression stability and it can also take information of samples grouping to define intra-and inter-group variations for each candidate reference gene. The result is an optimum rank of reference genes. 37 BestKeeper determines the most stably expressed genes based on the coefficient of correlation to the BestKeeper Index, which is the geometric mean of the candidate reference gene Ct values.
BestKeeper also calculates the standard deviation (SD) so that the best reference genes are those with the lowest SD and coefficient of variation (CV) based on the Ct values of all candidate reference genes. 38 Following these four analyses, each candidate reference gene obtained a specific ranking value. A consensual analysis was finally performed by the calculation of the geometric mean of the four ranking values for each gene leading to a consensus variability score for each reference gene.
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PPP2CA and ADCY5 were selected to confirm the appropriate reference genes pool by measuring their relative expression levels. TaqMan Array Cards were also used to perform real-time PCR experiments under the same experimental conditions and with the subset of samples indicated in Table 1 . For each group, an average Ct was calculated. The average Ct of the control groups, Sinus Rhythm without atrium dilatation (SRnd) and CT, was used as calibrator for the atria and ventricles, respectively. The determination of the relative gene expression ratio was achieved using the DDCt method, i.e. it is calculated by referring to the calibrator and normalized by a housekeeping gene or the geometric mean of a set of stable housekeeping genes.
Statistical analysis
Results are expressed as mean ± SEM. For statistical evaluation of two sets of data Mann-Whitney test was used. Kruskal-Wallis test was used for multiple comparisons to evaluate the significance between groups. A difference was considered statistically significant when P < 0.05.
Results
Total RNA sample concentration and quality
Total RNA content, 260/280 nm OD ratio and RIN obtained in the four human cardiac cavities under normal or pathological conditions are summarized in Table 3 . There were no differences in RNA content between the groups neither in the atria nor in the ventricles, or between atria and ventricles. The quality control parameters for human total RNA samples were similar regardless of human heart tissue sample collection, with no difference between the groups. The 260/280 nm OD ratios appeared relatively low (range of 1.5-1.7), but the RIN values were consistent and comparable within different heart cavities and cardiac diseases, with an overall average of 7.1.
Selection of candidate reference genes
Using RT-qPCR, we evaluated simultaneously the expression of 16 reference gene candidates on the 44 human heart tissue samples ( Table 1) . Figure 1 illustrates the variation in candidate reference gene abundance across all samples. For sake of clarity, the reference genes are ordered by their respective abundance. This first analysis showed as expected the dominance of 18S rRNA transcripts compared with the other reference genes. The other reference genes were separated into two groups according to their abundance: (i) ACTB, B2M, GAPDH, PGK1, PPIA, RPLP0, and UBC, with a median Ct value from 17 to 21; (ii) GUSB, HMBS, HPRT1, IPO8, POLR2A, TBP, TFRC, and YWHAZ with a median Ct value from 23 to 27. We found that some genes had a high variability in expression, e.g. 18S, ACTB, B2M, TBP, and TFRC, whereas others were more stable, e.g. HMBS and POLR2A. So, based on their relative abundance and steady expression across all the samples, a pre-selection of candidate reference genes could be considered.
We then performed a combined statistical analysis of the candidate reference gene variability by taking into account the results from the geNorm and NormFinder algorithms, the comparative Delta-Ct method and the BestKeeper software tool. The overall rank order of the most stable reference genes is shown in Table 4 for different comparisons across heart cavities and disease conditions. We summarized these results using a gene oblong chart to illustrate more easily the set of five reference genes that is the most suitable for normalizing gene expression data according to the considered heart cavity and cardiac disease (Figure 2) .
Concerning the right atrium, a first analysis including 20 patients in SR or AF and HF brought out the following set of five reference genes: POLR2A, GAPDH, PPIA, IPO8, RPLP0. This set of reference genes varied according to the progression from SR [SRnd or sinus rhythm with atrium (SRd)] to pAF and chronic atrial fibrillation (cAF), respectively, or depending on the type of cardiac pathology (AF vs. HF). The optimal set of reference genes for comparison of RA-SRnd vs. SRd appeared to be RPLP0, PPIA, POLR2A, B2M, and HMBS. RPLP0, together with PGK1, GAPDH, IPO8, and HMBS appear to represent a good choice as reference genes when comparing SRnd with pAF samples. In contrast, when the comparison includes cAF samples, RPLP0 is no more a reliable option; so, the best selection of reference genes includes POLR2A, PPIA, GAPDH, HPRT1, and PGK1. Based on these results, we propose GAPDH, IPO8, POLR2A, PPIA, and RPLP0 as an optimal set of reference genes to perform all the comparisons in the right atrium.
Regarding gene expression studies in all heart cavities, the results point to one common reference gene, POLR2A, among the top five for the RA/LA, RV/LV and A/V comparisons. GAPDH, GUSB, IPO8, and PPIA can be added to POLR2A which should warrant a minimal set of three to four reference genes for normalization of the RT-qPCR data.
GUSB appears as an appropriate reference gene when comparing ventricles in normal and pathological states. IPO8, PGK1, HMBS, and POLR2A can be added to GUSB when comparing left and right ventricles. For studies of HF in LV samples, the same genes can be used but YWHAZ could be preferred over POLR2A. However, to elucidate changes in gene expression related to HF in RV, GAPDH, POLR2A, GUSB, HPRT1, and PPIA represent the best set of reference genes. Altogether, a minimum of three reference genes among GAPDH, GUSB, IPO8, POLR2A and YWHAZ would provide a useful set to compare normal and failing ventricular cavities.
Among the 16 reference genes studied for their expression stability in healthy and pathological human heart cavities, our data also show that four genes should not be used for normalization: 18S, TBP, TFRC, and ACTB. Indeed, in each comparison presented in Table 4 , the two least stable genes belong to this set.
Finally, for a study comparing all cardiac chambers under normal and pathological conditions, a good set of reference genes should be: GAPDH, IPO8, POLR2A, PPIA, and YWHAZ or GUSB. Depending on the groups or conditions compared, this set of reference genes should lead to a minimal set of two to four reference genes to be used for normalization of RT-qPCR data.
Validation of the set of reference genes
We then tested our normalization strategy by comparing RT-qPCR data normalized to either 18S or to our final set of reference genes (GAPDH, IPO8, POLR2A, PPIA, and YWHAZ) for two genes of interest: PPP2CA in the right atrium from SR (SRnd or SRd), pAF and cAF patients; ADCY5 in the right ventricle from CTs and HF patients (Figure 3) .
A large and statistically significant difference in PPP2CA gene expression was found between cAF and the other groups when using 18S as reference gene for normalization ( Figure 3A) but not when using the set of reference genes for normalization ( Figure 3B) . Since earlier studies using a-actin as reference gene for the RT-qPCR experiments showed no change in PPP2CA gene expression in cAF, 41, 42 this validates the choice of the set of reference genes from our study when comparing human atrial tissues. Similarly, when comparing HF vs. CT ventricular samples, a significant increase in the expression level of ADCY5 was found in HF when normalization was made with the selected set of reference genes ( Figure 3D ) but the expression appeared unchanged between CT and HF samples when normalization was based only on 18S ( Figure 3C) . A similar absence of variation of ADCY5 mRNA between CT and HF was found in a pig model when normalizing to the expression of 18S. 43 In another study in dog heart, a decrease in ADCY5 expression was observed in HF when normalizing to the expression of ACTB, 44 one of least stable reference gene identified in our study. In contrast, an elevation of ADCY5 mRNA levels was found by Northern analysis in human ventricular samples from patients with HF when normalizing with GAPDH, 45 one of the best stable reference gene selected in this study. This validates the choice of the set of reference genes from our study when comparing human ventricular samples.
Discussion
In this study, we provide a detailed analysis of reference genes in cardiac tissues from different regions (right and left atria and ventricles) of the heart of patients with different pathological conditions. We show that Reference genes for transcriptomic analyses in human heart there is not one universal gene being appropriate to obtain a correct normalization for all types of human cardiac tissues. Based on a combined statistical analysis, we propose a set of most stable reference genes to be used when comparing RT-qPCR data obtained from healthy or diseased human cardiac tissues. A considerable number of studies used 18S or ACTB genes as internal controls for RT-qPCR analysis in heart samples. As shown earlier, 46 we found using three different algorithms (GeNorm, NormFinder, and Delta-Ct) that these genes, along with TBP and TFRC, are the two genes with the least stable expression in all our groups of samples (Table 4) . Accordingly, using one of these single commonly used reference genes to compare the level of expression of two genes of interest, PPP2CA and ADCY5, in healthy and diseased cardiac tissues led to misleading results, while on the contrary, using the geometric mean of our set of reference genes for normalization of the RT-qPCR data led to results that were consistent with the literature (Figure 3) . The choice of appropriate reference genes is, thus, of crucial importance when comparing RT-qPCR data from mRNA collected from different human heart samples. Although this issue has been addressed in a number of earlier studies, none of them provided a thorough and systematic analysis as performed here. We analysed 16 reference gene candidates and compared their level of expression and degree of stability in the four heart chambers and in control and diseased states. We found that GAPDH, IPO8, POLR2A, PPIA, and YWHAZ or GUSB provide an optimal set of genes to be used to normalize data in human heart tissue samples. PPIA has been shown earlier as an appropriate internal control gene in studies with atrial, 47 right ventricular 15, 47 and LV samples from healthy donors 15, 48 and from HF patients. 47 , 49 Martino et al. 47 also confirmed our findings about the use of HPRT1 as a reference gene in human atria and the use of GAPDH in right ventricle. These results are also in accordance with the study of Svobodová et al. 50 performed in pig heart.
Veseneti et al. 51 showed that HMBS, HPRT1 and YWHAZ are reliable ref-
erence genes when working with right or ischemic LV samples. However, together with Koppelkamm et al., 46 they identified TBP as an appropriate reference gene when studying LV samples, while our data indicate that expression of this gene is highly variable (Table 4) . However, TBP may be suitable as a reference gene only in combination with HMBS and HPRT1, and only in the remote region of the left ventricle in rats. 51 On the other hand, Koppelkamm et al. recommended the use of TBP in combination of at least three other reference genes, including HMBS, in post mortem cardiac muscle tissue with RIN mean values of 3.9. 46 Other studies, 49, 52 predominantly performed in left ventricles, showed that GAPDH is not a good reference gene. Our study shows that GAPDH expression is more stable in right than LV samples, and it can also be used as a reference gene in healthy and diseased atria and for comparison between atrial and ventricular tissues ( Figure 2 , Table 4 ). This is in agreement with recent works showing that GAPDH has the highest expression stability between the tested genes in both HF and healthy heart samples in right and left ventricle. 36, 53 POLR2A was ranked top three by the geometric consensus method for most atrial and RV studies, while IPO8 and GUSB were the most preserved reference genes in LV samples. This highlights the importance of choosing the most appropriate internal reference gene when studying chamber-specific differences in gene expression. To the best of our knowledge, IPO8 or GUSB have never been used as reference genes in human heart samples. An important aspect to take into consideration is the quality of the mRNA samples. It was shown earlier that the RIN values are lower and the variation in the RT-qPCR much larger in human than in rodent heart samples, 49 possibly due to differences in harvesting times or a consequence of the type and duration of the diseased condition. Thus, RNA integrity was carefully checked in our samples and the RIN values were consistent and comparable within the different heart cavities and cardiac diseases. Another important aspect is the method of analysis used to evaluate the variability in gene expression. Indeed, we compared the expression variability for the 16 reference gene candidates using four different methods of analysis (geNorm, Normfinder, BestKeeper and comparative delta-Ct) and found that each method could give a different ranking of the 16 genes ( Table 4) . This shows that using a single method of analysis to evaluate the relative expression of a gene cannot be recommended because this could lead to false-positive or false-negative results. We propose to use at least three methods of analysis and to calculate a geometric mean of the rankings as used here.
In conclusion, when performing RT-qPCR analysis on different samples obtained from different cardiac tissues and/or diseased states, we recommend (i) to use a normalization based on a set of three to five stable reference genes rather than on a single gene, and (ii) to use at least three methods of analysis of gene variability and calculate a geometric mean of the rankings to select the most robust set of reference genes. We validated this strategy in human heart using samples obtained from four cardiac chambers and up to five different pathophysiological conditions. Based on our combined results, we recommend the use of GAPDH, IPO8, POLR2A, PPIA, and YWHAZ or GUSB as reference genes for RT-qPCR when performing studies with human heart samples. 15.19 A, atrium; V, ventricle; RA, right atrium; LA, left atrium; RV, right ventricle and LV, left ventricle. SR, sinus rhythm, SRnd, sinus rhythm without atrium dilatation; SRd, sinus rhythm with atrium dilatation; AF, atrial fibrillation; pAF, paroxysmal atrial fibrillation; cAF, permanent atrial fibrillation; HF, heart failure; CT, healthy controls.
CT HF to illustrate the variability in PPP2CA and ADCY5 expression in different heart diseases depending on the selection of the reference gene. SRnd, atrial samples from patients in sinus rhythm without atria dilatation; SRd, atrial samples from patients in sinus rhythm with atria dilatation; pAF, atrial samples from patients with paroxysmal atrial fibrillation; cAF, atrial samples from patients with chronic atrial fibrillation; CT, right ventricle samples from healthy controls; HF, right ventricle samples from patients with heart failure. *P < _ 0.05 for comparisons as indicated.
